Koyfin Home > Directory > Health Care > Aratana Theraptcs > EBIT

Aratana Theraptcs EBIT Chart (PETX)

Aratana Theraptcs annual/quarterly EBIT from 2013 to 2018. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Aratana Theraptcs EBIT for the quarter ending December 12, 2018 was $-8m a 5.01% decrease of 0m year over year
  • Aratana Theraptcs EBIT for the last 12 months ending December 12, 2018 was $-11m a -185.44% increase of 21m year over year
  • Aratana Theraptcs Annual EBIT for 2018 was $-11m a -224.97% increase of 26m from 2017
  • Aratana Theraptcs Annual EBIT for 2017 was $-37m a 38.18% decrease of -14m from 2016
  • Aratana Theraptcs Annual EBIT for 2016 was $-23m a -106.96% increase of 24m from 2015
Other Income Statement Metrics:
  • Aratana Theraptcs EBITDA for the quarter ending December 12, 2018 was $-7m a 5.76% decrease of 0m year over year
  • Aratana Theraptcs Net Income for the quarter ending December 12, 2018 was $-9m a 1.00% decrease of 0m year over year
  • Aratana Theraptcs Total Revenue for the quarter ending September 09, 2018 was $22m a 51.49% increase of 11m year over year
View Chart On Koyfin

Quarterly PETX EBIT Data

12/2018$-8m
09/2018$9m
06/2018$-6m
03/2018$-7m
12/2017$-7m
09/2017$-8m
06/2017$-10m
03/2017$-12m
12/2016$-18m
09/2016$-13m

Annual PETX EBIT Data

2018$-11m
2017$-37m
2016$-23m
2015$-47m
2014$-39m
2013$-18m
2012$-10m